Community Involvement

Since 2013 Blue Water Energy has taken an active involvement in supporting local charities and community initiatives.

All of the charities we support have a direct link to someone in our team; we are therefore closer to the charities needs and their future plans and our understanding of this makes for a good partnership.

Currently supported charities are detailed below. Please take a look at their own websites to further understand the achievements and future plans of each.

For specific enquiries, please contact

  • Friends of ANCHOR

    The Aberdeen and North Centre for Haematology, Oncology and Radiotherapy (ANCHOR) unit is an NHS department at Aberdeen Royal Infirmary which treats patients with all forms of cancer, leukaemia and benign blood disorders throughout the North-east of Scotland including Orkney and Shetland. Friends of ANCHOR was set up to directly support the ANCHOR unit by committing long-term funding to the following three areas: (1) non-NHS funded equipment, (2) Patient Wellbeing and (3) Local Research.
  • Glencraft

    Glencraft is a social enterprise for crafts people with a variety of abilities and disabilities. Glencraft, founded in 1843, is a manufacturer of high quality mattresses, divans and furniture.
  • Greenhouse

    Greenhouse Sports is a London based charity that works full-time in schools and the community to provide outstanding sports programmes that nurture social, thinking, emotional and physical skills that equip young people for life.
  • Maggie's Aberdeen

    Maggie’s offers free practical, emotional and social support to people with cancer and their families and friends. Maggie’s has built multiple centres across the UK, including at the Aberdeen Royal Infirmary.
  • Supporting research into retinoblastoma with Moorfields Eye Hospital

    Through the support of Blue Water Energy and Tom and Helena Sikorksi, Moorfields Eye Hospital is pioneering research using next-generation sequencing technology into the treatment of retinoblastoma, the most common inherited cancer among children. As a result of this support, Moorfields hopes to develop more effective and less invasive treatments and enable earlier diagnosis, with the aim of targeted therapy.